Yield10 Bioscience (YTEN) Stock Price, News & Analysis

Company Overview

Yield10 Bioscience, Inc. is an agricultural bioscience company focused on developing breakthrough technologies to improve crop yield and oilseed composition. Headquartered in Woburn, Massachusetts, Yield10 leverages advanced gene editing, genome engineering, and metabolic engineering platforms to identify and optimize key genetic traits in food and feed crops. By targeting pathways such as photosynthesis efficiency and carbon use, the company aims to address global food security challenges and support sustainable agriculture.

Originally established as a subsidiary of Metabolix, Inc., Yield10 Bioscience was spun off in 2015 to concentrate exclusively on agricultural applications. Since then, the company has built a robust pipeline of trait development programs, including projects aimed at increasing seed oil content in Camelina sativa and pennycress, as well as enhancing yield potential in canola and soybean. Yield10’s pipeline features proprietary technologies such as the “Trait Factory” platform, which accelerates identification of genes that boost biomass and seed yield under field conditions.

Yield10 conducts research and field trials across North America in collaboration with public research institutions and strategic industry partners. Its multi‐phase approach includes greenhouse validation, confined field testing, and regulatory pathways to support commercial adoption. The company also explores development of specialty fatty acids and high-value crop traits that align with evolving market demands for plant-derived oils and agricultural commodities.

Under the leadership of CEO Oliver Peoples, Yield10 Bioscience is governed by a team of experienced scientists and business executives with deep expertise in biotechnology, agronomy, and commercial development. The company continues to pursue partnerships and licensing opportunities to accelerate the integration of its yield-improving traits into major row crops, positioning it at the forefront of next-generation crop innovation.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.0150 to $0.0150
• 52-Week Range: N/A
• Volume: 18 shs
• Average Volume: 78,164 shs
• Market Capitalization: $257 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

YTEN Stock Analysis - Frequently Asked Questions

How were Yield10 Bioscience's earnings last quarter?

Yield10 Bioscience, Inc. (NASDAQ:YTEN) released its earnings results on Tuesday, November, 9th. The specialty chemicals company reported ($11.76) earnings per share (EPS) for the quarter, beating the consensus estimate of ($15.60) by $3.84. The specialty chemicals company had revenue of $0.09 million for the quarter, compared to analysts' expectations of $0.22 million.

When did Yield10 Bioscience's stock split?

Yield10 Bioscience shares reverse split on the morning of Friday, May 3rd 2024.The 1-24 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of Yield10 Bioscience?

Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Yield10 Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Yield10 Bioscience investors own include Canopy Growth (CGC), Kushco (KSHB), NVIDIA (NVDA), Advanced Micro Devices (AMD), OPKO Health (OPK), Pfizer (PFE) and FuelCell Energy (FCEL).

Company Calendar

• Last Earnings: 11/09/2021
• Today: 7/12/2025
• Next Earnings (Estimated): 8/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Agricultural production - crops
• Sub-Industry: Agriculture
• Current Symbol: NASDAQ:YTEN
• CIK: 1121702
• Web: www.yield10bio.com
• Phone: (617) 583-1700
• Fax: 617-583-1768
• Employees: 30
• Year Founded: 1992

Profitability

• EPS (Trailing Twelve Months): ($26.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$14.45 million
• Net Margins: N/A
• Pretax Margin: -1,693.60%
• Return on Equity: N/A
• Return on Assets: -296.08%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.16
• Quick Ratio: 0.16

Sales & Book Value

• Annual Sales: $60 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($4.97) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 734,000
• Free Float: 689,000
• Market Cap: $257 thousand
• Optionable: Not Optionable
• Beta: 1.48